SI1093366T1 - Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles - Google Patents

Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles

Info

Publication number
SI1093366T1
SI1093366T1 SI9930696T SI9930696T SI1093366T1 SI 1093366 T1 SI1093366 T1 SI 1093366T1 SI 9930696 T SI9930696 T SI 9930696T SI 9930696 T SI9930696 T SI 9930696T SI 1093366 T1 SI1093366 T1 SI 1093366T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
composition containing
antiviral agent
gaba analogs
containing gaba
Prior art date
Application number
SI9930696T
Other languages
English (en)
Slovenian (sl)
Inventor
Leslie Magnus
Catherine A. Segal
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of SI1093366T1 publication Critical patent/SI1093366T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9930696T 1998-07-09 1999-06-18 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles SI1093366T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
EP99930482A EP1093366B1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (1)

Publication Number Publication Date
SI1093366T1 true SI1093366T1 (en) 2005-02-28

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930696T SI1093366T1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles

Country Status (17)

Country Link
EP (1) EP1093366B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002520300A (cg-RX-API-DMAC7.html)
KR (1) KR20010071776A (cg-RX-API-DMAC7.html)
AT (1) ATE279188T1 (cg-RX-API-DMAC7.html)
AU (1) AU765246B2 (cg-RX-API-DMAC7.html)
CA (1) CA2332929C (cg-RX-API-DMAC7.html)
DE (1) DE69921137T2 (cg-RX-API-DMAC7.html)
DK (1) DK1093366T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230863T3 (cg-RX-API-DMAC7.html)
ID (1) ID27395A (cg-RX-API-DMAC7.html)
NO (1) NO20010116D0 (cg-RX-API-DMAC7.html)
NZ (2) NZ508489A (cg-RX-API-DMAC7.html)
PL (1) PL345337A1 (cg-RX-API-DMAC7.html)
PT (1) PT1093366E (cg-RX-API-DMAC7.html)
SI (1) SI1093366T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000002592A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200007169B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4334900A (en) 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1274306C (zh) 2001-09-03 2006-09-13 纽朗制药有限公司 包含加巴喷丁或其类似物和α-氨基酰胺的药物组合物及其止痛应用
IN266803B (cg-RX-API-DMAC7.html) 2005-12-22 2015-06-03 Newron Pharm Spa
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
EA001214B1 (ru) * 1996-03-14 2000-12-25 Варнер-Ламберт Компани Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества
EP0934061B3 (en) * 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
EP1093366B1 (en) 2004-10-13
PT1093366E (pt) 2005-02-28
ES2230863T3 (es) 2005-05-01
DE69921137T2 (de) 2006-02-02
ZA200007169B (en) 2002-03-04
WO2000002592A1 (en) 2000-01-20
JP2002520300A (ja) 2002-07-09
ATE279188T1 (de) 2004-10-15
NO20010116L (no) 2001-01-08
CA2332929A1 (en) 2000-01-20
PL345337A1 (en) 2001-12-17
NZ508489A (en) 2004-06-25
AU765246B2 (en) 2003-09-11
DE69921137D1 (de) 2004-11-18
ID27395A (id) 2001-04-05
NO20010116D0 (no) 2001-01-08
KR20010071776A (ko) 2001-07-31
CA2332929C (en) 2005-05-31
EP1093366A1 (en) 2001-04-25
DK1093366T3 (da) 2004-12-06
NZ525623A (en) 2005-08-26
AU4701699A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
ZA976562B (en) Isobutylgaba and its derivatives for the treatment of pain.
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
AU2295895A (en) Dosage forms and method for ameliorating male erectile dysfunction
BR9809292A (pt) Métodos aperfeiçoados para o processamento de proteìna c ativada
PL345337A1 (en) Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
ATE243497T1 (de) Verfahren zur förderung des hautzellstoffwechsels
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
FR2401659A1 (fr) Composition destinee a ameliorer le pouvoir reproducteur des animaux, contenant une association a base de l-dopa et d'un acide amine
NZ337798A (en) Pharmaceutical compositions containing lamivudine
GR3024491T3 (en) Enzymatic resolution of a racemic mixture of stereospecific gaba-t inhibitors.
WO2000002545A3 (en) Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain
BR9911925A (pt) O tratamento de cólica renal com análogos de gaba
BR9911950A (pt) Composição farmacêutica contendo análogos gaba e um agente antiviral para tratamento de herpes zoster